The relationship between admission serum calcium levels and in-hospital mortality in patients with acute ST-segment elevation myocardial infarction (STEMI) has not been well definitively explored. The objective was to assess the predictive value of serum calcium levels on in-hospital mortality in STEMI patients.
From 2003 to 2010, 1431 consecutive STEMI patients admitted to the First Affiliated Hospital of Nanjing Medical University were enrolled in the present study. Patients were stratified according to quartiles of serum calcium from the blood samples collected in the emergency room after admission. Between the aforementioned groups,the baseline characteristics, in-hospital management, and in-hospital mortality were analyzed. The association of serum calcium level with in-hospital mortality was calculated by a multivariable Cox regression analysis.
Among 1431 included patients, 79% were male and the median age was 65 years (range, 55–74). Patients in the lower quartiles of serum calcium, as compared to the upper quartiles of serum calcium, were older, had more cardiovascular risk factors, lower rate of emergency revascularization,and higher in-hospital mortality. According to univariate Cox proportional analysis, patients with lower serum calcium level (hazard ratio 0.267, 95% confidence interval 0.164–0.433, p<0.001) was associated with higher in-hospital mortality. The result of multivariable Cox proportional hazard regression analyses showed that the Killip's class≥3 (HR = 2.192, p = 0.026), aspartate aminotransferase (HR = 1.001, p<0.001), neutrophil count (HR = 1.123, p<0.001), serum calcium level (HR = 0.255, p = 0.001), and emergency revascularization (HR = 0.122, p<0.001) were significantly and independently associated with in-hospital mortality in STEMI patients.
Serum calcium was an independent predictor for in-hospital mortality in patients with STEMI. This widely available serum biochemical index may be incorporated into the current established risk stratification model of STEMI patients. Further studies are required to determine the actual mechanism and whether patients with hypocalcaemia could benefit from calcium supplement.
Citation: Lu X, Wang Y, Meng H, Chen P, Huang Y, Wang Z, et al. (2014) Association of Admission Serum Calcium Levels and In-Hospital Mortality in Patients with Acute ST-Elevated Myocardial Infarction: An Eight-Year, Single-Center Study in China. PLoS ONE 9(6): e99895. https://doi.org/10.1371/journal.pone.0099895
Editor: Alexander G. Obukhov, Indiana University School of Medicine, United States of America
Received: January 8, 2014; Accepted: May 19, 2014; Published: June 13, 2014
Copyright: © 2014 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Project supported by the National Natural Science Foundation of China (No. 81170102/H0203), the Priority Academic Program Development of Jiangsu Higher Education Institutions (BL2012011), the Chinese Medical Association of the Sunlight Foundation (SCRFCMDA201217), the Fourth Period Progect “333” of Jiangsu Province (BRA2012207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Calcium, one of the most important cations, plays a critical role in cardiac contraction, enzymatic activity, and electrophysiological characteristics. The steady state of calcium flux balance is significantly necessary for myocardium . Previous studies have reported that high serum calcium concentration is an independent predictor for the incidence of coronary heart disease (CHD) including acute myocardial infarction (AMI); it is also tightly tied to the cardiovascular risk factors such as hypertension, hyperglycemia, and hyperlipidemia –. Meanwhile, some other prior studies have demonstrated that acute hypocalcaemia is a common electrolyte disturbance of critically ill patients, particularly in patients with sepsis, acute necrotic pancreatitis, trauma, severe burns, rhabdomyolysis, as well as the systemic inflammatory response syndrome (SIRS), and it has been shown to predict increased mortality and poor outcomes –. As one of common urgent critically illnesses, acute ST-segment elevation myocardial infarction (STEMI) has heightened neurohormonal activation, impaired gastrointestinal function, renal insufficiency, which all could affect calcium homeostasis. However, to date, few studies are concentrated on the prognostic role of varying calcium levels in in-hospital patients with STEMI. Thus, the current evidence for an association between them remains unclear. Therefore, we performed the present analysis to evaluate the impact of the baseline serum calcium levels on the risk of in-hospital all-cause mortality for patients hospitalized with STEMI.
Materials and Methods
From January 2003 to December 2010, a total of 1431 consecutive STEMI patients admitted to the First Affiliated Hospital of Nanjing Medical University were enrolled in the study. The STEMI was defined as: typical continuous chest pain>30 min with ST-segment elevation>2.0 mm in at least 2 contiguous electrocardiographic leads, and more than a two-fold elevation in the creatine kinase-MB (CK-MB) level . Exclusion criteria were, presence of chest pain>24 hours, hepatic dysfunction and/or renal dysfunction, parathyroid diseases, evidence of infection within the last 2 week, history of malignancy within the past 3 years, major trauma or surgery within a week before admission and missing laboratory values. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (Nanjing, China). Written informed consent was received from all patients. Data obtained from medical records, laboratory investigations and clinical case histories were retrospectively reviewed. Follow-up data were collected at discharge or demise time. Among these patients, there were 1131 men and 300 women and the median age was 65 years (range, 55–74). For each patient, a routine initial clinical assessment including clinical history, physical examination, pulse oximetry, the standard 12-lead electrocardiogram (ECG) and continuous ECG monitoring, was carried out. The thrombolysis in myocardial infarction (TIMI) risk score for STEMI  was calculated for each subject on admission and used to assess risk within this study population.
Blood Sampling and Laboratory Analyzes
The blood samples were collected in the emergency room from each patient after admission. In all cases, peripheral venous blood samples for hematologic and biochemical measurements were drawn. The concentrations of calcium (mmol/L), sodium (mmol/L), potassium (mmol/L), and chloride (mmol/L) were measured with the VITROS 5–1 FS chemistry system (Ortho Clinical Diagnostics, Raritan, NJ). Hypocalcaemia was defined as the concentrations of serum calcium<2.15 mmol/L according to reference range. Common blood counting parameters, in general, including the total white blood cell count, neutrophil count, eosinophil count, monocyte count, lymphocyte count, and addicted Alkaline granulocyte count, were measured by an automatic hematology analyzer (Bayer Diagnostics ADVIA120). Meanwhile, the levels of albumin (g/L), HDL-cholesterol (mmol/L), LDL-cholesterol (mmol/L) and aspartate aminotransferase (U/L) were analyzed by the AU2700 automatic biochemical analyzer.
Statistical analysis was performed by SPSS 16.0 (SPSS, Chicago, Illinois, USA) and SAS version 9.1 (SAS Institute Inc., Cary, NC). The Kolmogorov–Smirnov test was used to test continuous variables for normal distribution. Normally distributed data, including neutrophil count, TIMI risk score for STEMI, albumin, serum potassium, onset-arrival time and the length of hospitalization were expressed as mean ± standard deviation and comparisons were analyzed by one-way ANOVA among the quartiles. Skewed data, including age, heart rate, high density lipoprotein (HDL)-cholesterol, Low density lipoprotein (LDL)-cholesterol, Peak creatine kinase (CK), Troponin-T, left ventricular ejection fraction (LVEF), aspartate aminotransferase (AST), serum chlorine, serum sodium, were expressed as the median (inter quartile range) and compared by the Kruskal-Wallis H test. Categorical variables were summarized as percentages and compared among the groups by Chi-squared analysis. The cumulative survival curves for in-hospital mortality with different quartiles of serum calcium were constructed using the Kaplan–Meier method, and curves were compared by the log–rank test. The multivariable Cox proportional hazards regression analyses using forward likelihood ratio tests were performed to explore the independent importance of the variables for in-hospital mortality. The assumptions of proportional hazards were assessed by including time dependent covariates in the models and no indication of a violation was found. The linearity of the continuous variables was checked with Martingale residuals. To avoid over fitting, the following variables known to affect prognosis after STEMI were considered in the multivariable Cox regression analyses model: age, gender, Killip's class, LVEF, AST, neutrophil count, albumin, serum calcium level, emergency revascularization. The multivariable analyses were performed in 2 separate multivariable Cox models, with serum calcium entered as continuous data, or stratified by quartiles. All P-values were 2-tailed and P-value<0.05 was considered statistically significant.
In this present study, a total of 1431 patients admitted to our department with STEMI were enrolled, and the information about serum calcium of each patient was available at the time of hospital admission. The admission serum calcium levels were normally distributed (Figure 1) with a mean admission calcium level of 2.25±0.21 (mmol/L). Based on the serum calcium upon admission, patients were stratified into quartiles (1st quartile: <2.14, 2nd quartile: 2.14-<2.25, 3rd quartile: 2.25-<2.36 and 4th quartile: >2.36). The baseline characteristics of patients according to serum calcium quartiles are presented in Table 1. Median age decreased as the serum calcium increased [69(59–75), 66(57–74), 65(55–74), 60(52–70), p<0.001 for trend across quartiles], while gender showed no difference significantly across quartiles of serum calcium. The traditional risk factors of coronary artery disease including hypertension, stroke history, diabetes mellitus and smoking status, did not differ among the quartiles. Patients in the lower quartiles of serum calcium, as compared to the upper quartiles of serum calcium, were more likely to be presented with higher TIMI risk score for ST-segment MI (p<0.001) upon admission. According to laboratory data on admission, these patients were also associated with a lower level of albumin, serum sodium and serum potassium, as well as a higher level of neutrophil count and troponin-T. Moreover, the level of HDL-cholesterol, LDL-cholesterol, AST, and Killip's class≥3, differed significantly across the serum calcium quartiles (p = 0.020, p<0.001, p<0.001, p<0.001, p = 0.011, respectively). In contrast, there was no statistically significant distinction between the aforementioned groups and the infarcted region, onset-arrival times, peak CK, LVEF, as well as serum chlorine level.
The admission serum calcium levels were normally distributed with a mean admission calcium level of 2.25±0.21 (mmol/L).
In-hospital Management and Clinical Outcome
The in-hospital management and mortality of patients according to serum calcium quartiles are listed in Table 2. Overall, 1026 patients with STEMI underwent emergency revascularization therapy by percutaneous coronary intervention (PCI) (71.7%). The rate of emergency revascularization exhibited significant distinction among quartiles (p = 0.001 for trend across quartiles), but not for the rate of elective revascularization (p = 0.147). Furthermore, there was no significant disparity in the length of hospitalization and the administration of pharmacologic agents, including antiplatelets, beta-blockers, nitrates, angiotensin-converting enzyme inhibitors (ACEI), and/or angiotensin receptor blockers (ARB), calcium antagonists, statins, and heparin/low molecular heparin. In addition, a lower in-hospital mortality was observed as the serum calcium quartiles increased (12.7%, 6.5%, 4.4%, 2.9%, p<0.001 for trend across quartiles). Kaplan-Meier curves for in-hospital cumulative mortality showed that the mortality was higher in patients with hypocalcemia (Figure 2).
Patients were stratified by quartiles of serum calcium. The comparisons among the groups were performed using the log rank test.
Survival and Predictive Factors of In-hospital Mortality
Table 3 shows univariate and multivariable Cox proportional hazard regression analyses of factors associated in-hospital mortality. For in-hospital mortality, age, gender, Killip's class≥3, neutrophil count, serum calcium, aspartate aminotransferase, albumin and emergency revascularization were analyzed using a multivariable Cox proportional hazard regression model. And then eventually, five independent predictors of in-hospital mortality emerged in this series: Killip's class≥3 [hazrad ratio (HR) 2.192, p = 0.026)], AST (HR = 1.001, p<0.001), neutrophil count (HR = 1.123, p<0.001), serum calcium level (HR = 0.255, p = 0.001), and emergency revascularization (HR = 0.122, p<0.001). In univariate analysis, every 1- µmol/L increase in serum calcium was associated with lower in-hospital mortality (HR = 0.267, 95% confidence interval (CI) 0.164–0.433, p<0.001). After adjustment for potentially confounding variables, serum calcium level was still an independent predictor of in-hospital mortality (HR = 0.255, 95% CI 0.114–0.572, p = 0.001), indicating that lower serum calcium level was associated with higher mortality probability. When stratified by quartiles, the upper quartile of serum calcium level was associated with a decreased risk of in-hospital mortality (HR = 0.753, 95% CI 0.612–0.928, p = 0.009), compared with the lowest quartile.
The present study was conducted to evaluate the relationship between the admission serum calcium levels and in-hospital mortality of 1431 consecutive patients with STEMI. The result of this study documented that a decreased baseline serum calcium level measured on admission was associated with higher in-hospital all-cause mortality, even after adjusting for the possible confounding predictors. The highest mortality was observed among patients with serum calcium concentration less than 2.14 mmol/L. These findings highlighted that declined serum calcium concentration is a predictor of short term mortality for STEMI rather than just a marker of an acute medical condition. Although there was a significant higher frequency of some cardiovascular risk factors in patients with low serum calcium level, it did not interfere with the significant prognostic effect of serum calcium on in-hospital mortality among STEMI patients in the multivariable analysis.
A considerable number of clinical studies have suggested that hypocealcemia is a common electrolyte disturbance among critically ill patients and it has been shown to be associated with increased mortality –. Our study demonstrated, for the first time, that in STEMI patients, serum calcium held a prognostic role for in-hospital mortality. Compared with those whose serum calcium concentrations were normal, patients with hypocalcaemia tended to be older, with lower blood pressure, lower concentration of serum albumin, higher TIMI risk score for STEMI and higher neutrophil count on admission. They were also strongly associated with lower emergency revascularization rate, which could improve myocardial salvage and evidently made a difference in acute myocardial infarction (AMI) mortality , . Numerous researchers have reported the independent predicative value of neutrophil count for in-hospital and long-term mortality in STEMI patients ,  along with the mechanisms about inflammation reaction . The results of our study are consistent with the above study. Moreover, it has been well established that less than half of total serum calcium is protein bound, principally to albumin . In the present study, although albumin level seemed to be significantly lower in hypocalcaemia group, all data were within a small zone and the normal range. As the albumin level was also included in the multivariable Cox regression model, the interference of the albumin on serum calcium could be eliminated. In addition, another finding of this study was that AST was also a predictor for in-hospital mortality which was similar to the study by Chiara Lazzeri et al. .
Calcium plays a critical role in osteogenic function, signalling function  and enzymatic function. An increasing level of intracellular calcium in platelet is one of the most important links in atherosclerotic plaques formation or thrombogenesis process in CHD , thus calcium is consumed, which induces hypocalcaemia in these patients . Since the emergency revascularization rate and TIMI risk score for STEMI in this study was significantly associated with serum calcium level, the assumption was that low calcium level might partially reflect worsened vascular condition in patients. The lower calcium level was, the more plaques or thrombus were formed , and the smaller chance of revascularization would be. In this present study, older patients had a lower level of serum calcium after STEMI, this may be associated with worse regulation of calcium, higher incidence of osteoporosis, and less chance to survive in critical ill.
The mechanism which may account for the association between the admission serum calcium levels and in-hospital mortality with STEMI was unknown. However, intracellular calcium overload may play a key role. Intracellular calcium acts as a second messenger  for the secretion of some hormones and neurotransmitters, as well as an intracellular permeation regulator and mediator of muscle contraction . The decreased serum calcium concentration would increase the calcium channels on vascular smooth muscle cells (VSMCs), and increase the level of intracellular calcium, which is known as “the abnormal calcium influx” . This change would play an important role in the process of cell migration  and atherosclerotic plaques formation . Extracellular calcium content is nearly 10000 times over intracellular calcium and lots of complex mechanisms involved in maintaining this concentration ladder. Boya et al. reported that calcium influx would cause chondriosome swollen and then lead to a series of cellular toxin damage . The dysfunction of vascular endothelial cells leads to more lipid deposition and thrombus formation , thus increases ionized calcium consumption. Therefore, a hypocalcaemia vicious cycle is formed. Cell toxin damage would aggravate inflammation in STEMI patients, which also plays an important role in coronary pathology and formation of plaque . In this study, neutrophils count, an inflammation factor, was significantly higher in hypocalcaemia group, which was similar to Meissner et al's study . Thus, the results from the above studies are consistent with those of our study where hypocalcaemia patients own worse vascular condition than those with normal calcium level, and may have more severe coronary damage and worse prognosis.
A large number of studies reached the conclusion that calcium intake were associated with the incidence of heart disease –. Recently, researchers claimed that both the subjects in the low and high level of serum calcium had higher rate of cardiovascular disease incidence . However, the results are inconsistent between men and women. Women seem to have high ischemic heart disease (IHD) mortality in high serum ionized calcium group, while men have high risk of IHD death in low calcium group. What's more, men seem to benefit more from daily calcium supplement than women prospectively, although there were no strong evidence between dietary calcium intake and cardiovascular disease death. A reported prospective study suggested that systolic blood pressure and left ventricular stroke work index increaseds after slowly calcium intravenous injection to critically ill patients complicated by hypocalcaemia . Calcium administration for STEMI patients with hypocalcaemia may be beneficial for short term outcome of post-AMI, but this still needs solid evidence to prove.
The advantages of our study are a large patient population and the comprehensive available laboratory data, but there are still some limitations in our present study. First, our study protocol is designed as a retrospective, observational, and single-center study rather than a prospective multi-center cohort study. Second, as some sufferers who died before reaching hospital, and these missing data may lead to an underestimated mortality rate in patients with STEMI. Finally, the mechanism of the associations between hypocalcaemia and in-hospital mortality in STEMI is still unclear. Although serum calcium concentration is significantly associated with in-hospital mortality in STEMI in the present study, the clinical significance of this finding needs further investigation.
Serum calcium was an independent predictor for in-hospital mortality in STEMI patients. This widely available serum biochemical index may help identify high-risk STEMI individuals, who might benefit from more aggressive interventions. However, the actual pathophysiologic mechanism and whether patients with hypocalcaemia could benefit from calcium supplement requires further study.
Conceived and designed the experiments: ZY EJ XL. Performed the experiments: XL YW HM PC. Analyzed the data: XL YH CL LW. Contributed reagents/materials/analysis tools: ZW NZ. Wrote the paper: XL YW ZY. Helped to write the manuscript: ZY.
- 1. Eisner D, Bode E, Venetucci L, Trafford A (2013) Calcium flux balance in the heart. J Mol Cell Cardiol 58: 110–7.
- 2. Lind L, Jakobsson S, Lithell H, Wengle B (1988) Ljunghall (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297(6654): 960–3.
- 3. Jorde R, Sundsfjord J, Fitzgerald P, Bonaa KH (1999) Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 34(3): 484–90.
- 4. Lundgren E, Lind L, Palmer M, Jakobsson S, Ljunghall S, et al. (2001) Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 130(6): 978–85.
- 5. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50(8): 967–73.
- 6. Hadjis T, Grieff M, Lockhat D, Kaye M (1993) Calcium metabolism in acute renal failure due to rhabdomyolysis. Clin Nephrol 39(1): 22–7.
- 7. Muller B, Becker KL, Kranzlin M, Schachinger H, Huber PR, et al. (2000) Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur J Clin Invest 30(9): 823–31.
- 8. Cherry RA, Bradburn E, Carney DE, Shaffer ML, Gabbay RA, et al. (2006) Do early ionized calcium levels really matter in trauma patients? J Trauma 61(4): 774–9.
- 9. Szyfelbein SK, Drop LJ, Martyn JA (1981) Persistent ionized hypocalcemia in patients during resuscitation and recovery phases of body burns. Crit Care Med 9(6): 454–8.
- 10. Hastbacka J, Pettila V (2003) Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand 47(10): 1264–9.
- 11. Frick TW (2012) The role of calcium in acute pancreatitis. Surgery 152(3 Suppl 1)S157–63.
- 12. Choi YC, Hwang SY (2008) The value of initial ionized calcium as a predictor of mortality and triage tool in adult trauma patients. J Korean Med Sci 23(4): 700–5.
- 13. Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007) Universal definition of myocardial infarction. Circulation 116(22): 2634–53.
- 14. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, et al.. (2000) TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102(17): p. 2031–7.
- 15. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, et al. (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26(8): 804–47.
- 16. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, et al. (2009) 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54(23): 2205–41.
- 17. Kaya MG, Akpek M, Lam YY, Yarlioglues M, Celik T, et al. (2013) Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study. Int J Cardiol 168(2): 1154–9.
- 18. Meissner J, Irfan A, Twerenbold R, Mueller S, Reiter M, et al. (2001) Use of neutrophil count in early diagnosis and risk stratification of AMI. Am J Med 124(6): 534–42.
- 19. Baxter GF (2002) The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 97(4): 268–75.
- 20. Walker BE, Payne RB (1979) Adjusted calcium conflict resolved? Differing effects on plasma total calcium of changes in plasma albumin after venous stasis or myocardial infarction. J Clin Pathol 32(5): 488–91.
- 21. Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, et al. (2010) Prognostic values of admission transaminases in ST-elevation myocardial infarction submitted to primary angioplasty. Med Sci Monit 16(12): CR567–74.
- 22. Hovis JG, Meyer T, Teasdale RM, Albrecht BN, Yorek MA, et al. (1993) Intracellular calcium regulates insulin-like growth factor-I messenger ribonucleic acid levels. Endocrinology 132(5): 1931–8.
- 23. Varga-Szabo D, Braun A, Nieswandt B (2009) Calcium signaling in platelets. J Thromb Haemost 7(7): 1057–66.
- 24. Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, et al. (2010) Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study. Platelets 21(5): 360–7.
- 25. Cross KM, Dahm LM, Bowers CW (2000) Simultaneous measures of contraction and intracellular calcium in single, cultured smooth muscle cells. In Vitro Cell Dev Biol Anim 36(1): 50–7.
- 26. Campillo-Soto A, Liron-Ruiz R, Gervasio Martin-Lorenzo J, Flores-Pastor B (2009) Deconstructing the myth of using serum parathormone as a predictor of hypocalcaemia after total thyroidectomy. Cir Esp 86(6): : 391–2; author reply 392–3.
- 27. Pettit EJ, Fay FS (1998) Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis. Physiol Rev 78(4): 949–67.
- 28. Clunn GF, Lymn JS, Schachter M, Hughes AD (1997) Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells. Br J Pharmacol 121(8): 1789–95.
- 29. Boya P, Roques B, Kroemer G (2001) New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. EMBO J 20(16): 4325–31.
- 30. Chulkova TM (1989) The role of thrombus formation processes in atherosclerosis (review). Vopr Med Khim 35(4): 2–8.
- 31. Libby P, Okamoto Y, Rocha VZ, Folco E (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74(2): 213–20.
- 32. Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S (2013) Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One 8(4): e61037.
- 33. Vincent JL, Bredas P, Jankowski S, Kahn RJ (1995) Correction of hypocalcaemia in the critically ill: what is the haemodynamic benefit? Intensive Care Med 21(10): 838–41.